Home
>
National Drug Code (NDC)
>
Tamoxifen Citrate
Tamoxifen Citrate - 60505-3035-3 - (Tamoxifen Citrate)
Drug Information of Tamoxifen Citrate
| Product NDC: | 60505-3035 |
| Proprietary Name: | Tamoxifen Citrate |
| Non Proprietary Name: | Tamoxifen Citrate |
| Active Ingredient(s): | 10 mg/1 & nbsp; Tamoxifen Citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tamoxifen Citrate
| Product NDC: | 60505-3035 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090878 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121130 |
Package Information of Tamoxifen Citrate
| Package NDC: | 60505-3035-3 |
| Package Description: | 30 TABLET in 1 BOTTLE (60505-3035-3) |
NDC Information of Tamoxifen Citrate
| NDC Code | 60505-3035-3 |
| Proprietary Name | Tamoxifen Citrate |
| Package Description | 30 TABLET in 1 BOTTLE (60505-3035-3) |
| Product NDC | 60505-3035 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tamoxifen Citrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121130 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | TAMOXIFEN CITRATE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
